A former Netflix Inc.
(NASDAQ:NFLX) executive has accused the streaming giant of wrongful termination, alleging the company fired him after he disclosed medically prescribed ketamine therapy during a workplace trust-building exercise.
Ex-Netflix Exec Says Trust Exercise Disclosure Sparked Investigation Kevin Baillie, the former vice president and head of creative at Eyeline Studios, a Netflix-owned visual effects division, has sued the company, the New York Post reported on Sunday.
Baillie claimed that he lost his $1.1 million-a-year job after revealing he had undergone physician-supervised ketamine therapy for depression.
According to the lawsuit, Baillie received the treatment in October and November 2022 at a clinic in Santa Barbara following the death of his mother.
